Q-linea AB Stock

QLINEA

SE0025420714

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 15:30:00 30/10/2026 +03			5-day change	1st Jan Change
14.90 ^SEK	+1.36%		-6.58%	-40.26%

04:20pm	Q-linea AB, Q3 2026 Earnings Call, Oct 30, 2026
12:24pm	Nine stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW

Last Transcript: Q-linea AB

Q-linea AB, Q3 2026 Earnings Call, Oct 30, 2026

04:20pm

More transcripts

Analysts' recommendations: Q-linea AB

19/09/25	Redeye Lowers Fair Value for Q-linea to 55 SEK (Previously 60 SEK)	FW
03/03/25	Redeye lowers motivated value for Q-linea to SEK 0.13 (0.20)	FW
10/01/25	Substantial dilution to be expected in Q-linea, Redeye lowers motivated value	FW
02/01/25	Precise and Isofol 2024 winners on Nasdaq Stockholm, Xbrane and Fingerprint losers of the year	FW
04/03/24	Redeye lowers motivated value for Q-linea - revises sales forecast downwards	FW

More recommendations

Managers and Directors: Q-linea AB

Manager	Title	Age	Since
Stuart Gander CEO	Chief Executive Officer	48	19/10/2025
Annika Blondeau Henriksson DFI	Director of Finance/CFO	57	15/06/2026
Anders Lundin DFI	Director of Finance/CFO	62	01/01/2018

Director	Title	Age	Since
Jonas Jarvius BRD	Director/Board Member	55	01/03/2024
Erika Kjellberg-Eriksson CHM	Chairman	64	01/01/2018
Mario Gualano BRD	Director/Board Member	57	26/05/2020

More insiders

Medical Diagnostic & Testing Equipment

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
Q-LINEA AB	+1.36%	-6.58%	-40.57%	-99.49%	28.25M
THERMO FISHER SCIENTIFIC, INC.	-0.60%	+4.91%	+27.09%	+62.83%	262B
DANAHER CORPORATION	-1.15%	+2.51%	+9.87%	+27.65%	167B
INTUITIVE SURGICAL, INC.	-0.32%	-0.92%	-15.45%	+73.36%	156B
BOSTON SCIENTIFIC CORPORATION	+1.02%	-6.53%	-57.54%	-14.68%	61.87B
EDWARDS LIFESCIENCES CORPORATION	+0.23%	+6.71%	+13.85%	+52.41%	54.44B
SIEMENS HEALTHINEERS AG	+0.70%	+3.27%	-11.27%	-5.55%	53.3B
AGILENT TECHNOLOGIES, INC.	-2.28%	+3.35%	+24.77%	+76.80%	51.07B
VEEVA SYSTEMS INC.	+1.06%	-3.32%	+9.57%	+64.13%	50.25B
WATERS CORPORATION	-1.94%	+5.55%	+39.64%	+102.30%	47.17B
Average	-0.15%	+0.70%	-0.00%	+33.98%	90.26B
Weighted average by Cap.	-0.44%	+2.44%	+7.26%	+51.09%

See all sector performances

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-30 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	SEK 14.90	+1.36%	16,119
29/10/26	SEK 14.70	-2.00%	27,015
28/10/26	SEK 15.00	-1.96%	2,086
27/10/26	SEK 15.30	-2.55%	6,993
26/10/26	SEK 15.70	-1.57%	12,175

Delayed Quote Nasdaq Stockholm

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Q-linea AB

Company calendar

Market Cap	279M 28.25M 25.31M 23.35M 21.13M 39.51M 2.69B 40.15M 111M 1.41B 106M 104M 4.46B	P/E 2024	-0.37x	P/E 2025	-0.91x
Enterprise Value	26.29M 2.67M 2.39M 2.2M 1.99M 3.73M 254M 3.79M 10.49M 133M 10.01M 9.79M 421M	EV / Sales 2024	49.8x	EV / Sales 2025	14.4x
Free-Float	87.11%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Nasdaq Stockholm	QLINEA	Delayed
Deutsche Boerse AG	3F80	Delayed
CBOE		Real-time
CBOE		Real-time
Boerse Muenchen	3F80	Real-time
CBOE	QLINEs	Real-time

04:20pm	Q-linea AB, Q3 2026 Earnings Call, Oct 30, 2026
12:24pm	Nine stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange	FW
09:42am	Q-linea increases revenue and reduces operating loss	FW
10-29	Calendar Friday, October 30	FW
08-20	Sweden's Q-linea Names New Finance Chief	MT
08-20	Q-linea appoints Malin Svensson as new CFO	FW
08-20	Q-linea Appoints New CFO	FW
08-20	Q-linea AB Announces Appointment of Malin Svensson to Chief Financial Officer, Effective No Later Than January 1, 2027	CI
08-20	Q-linea AB Announces Appointment of Malin Svensson as Head of Investor Relations, Effective January 1, 2027	CI
08-18	Stockholm stocks fell again on Tuesday, the OMXS30 index slipped 0.7 percent	FW
08-18	Stocks extend losses in Stockholm, OMXS30 index down 0.5 percent	FW
08-18	Q-linea Wins Contract for ASTar System in US	MT
08-18	Q-linea signs master agreement with US purchasing organization Premier	FW

08-20	Q-linea appoints Malin Svensson as new Chief Financial Officer	AQ
08-18	Q-linea awarded a contract position with Premier, Inc.	AQ
08-10	Q-linea Announces ASTar® Contract With Large Health System in the U.S. Mid-Atlantic Region	AQ
07-10	Q linea : Interim report January 1 - June 30 2026	PU
05-29	Annika Blondeau Henriksson new interim CFO	AQ

1 day	+1.36%
1 week	-6.58%
Current month	-14.86%
1 month	-14.86%
3 months	-19.46%
6 months	-11.83%
Current year	-40.26%

Q-linea AB Stock

Stocks

QLINEA

SE0025420714

Advanced Medical Equipment & Technology

Valuation: Q-linea AB

Chart: Q-linea AB

Latest news: Q-linea AB

Last Transcript: Q-linea AB

Analysts' recommendations: Q-linea AB

Press Releases: Q-linea AB

Quotes and Performance

Price Extremes

Managers and Directors: Q-linea AB

Latest insider transactions

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

1 week	14.05	15.85
1 month	14.05	17.65
Current year	14.05	38.42
1 year	14.05	38.42
3 years	14.05	5,600
5 years	14.05	145,000
10 years	14.05	187,500

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/21/25 A	Johan Bygge	Buy	Chairman	4,000	0.0207%
11/12/25 A	Stuart Gander	Exercice	Chief Executive Officer	35,400	0.1833%
11/11/25 A	Erika Kjellberg-Eriksson	Buy	Director	19,740	0.1022%

	2024	2025
Net sales	4.14M 420K 376K 347K 314K 587K 39.98M 597K 1.65M 20.92M 1.58M 1.54M 66.27M	15.28M 1.55M 1.39M 1.28M 1.16M 2.17M 148M 2.2M 6.1M 77.27M 5.82M 5.69M 245M
Net income	-217M -22M -19.7M -18.18M -16.45M -30.76M -2.09B -31.26M -86.52M -1.1B -82.56M -80.8M -3.47B	-182M -18.51M -16.58M -15.3M -13.84M -25.88M -1.76B -26.3M -72.8M -923M -69.47M -67.99M -2.92B
Net Debt	126M 12.73M 11.41M 10.52M 9.52M 17.81M 1.21B 18.09M 50.08M 635M 47.79M 46.77M 2.01B	-252M -25.59M -22.92M -21.14M -19.13M -35.78M -2.44B -36.36M -101M -1.28B -96.03M -93.98M -4.04B